MindMed begins the first Phase 1 clinical trial testing the safety and tolerance of MDMA and LSD in combination.
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
Entheon announces a new partnership to advance its psychedelic drug R&D.
CYBIN Announces Upsize to Previously Announced Bought Deal Offering
Cybin's bought deal financing has been upsized to CAD$30 million.
Low Tide For Psychedelic Stocks With Media, Investors Distracted
The U.S. election has become a major political circus. With investors distracted and the media focused elsewhere, psychedelic stocks are temporarily at low tide.
Cybin Announces CDN$20 Million Bought Deal Offering
Cybin Corp announces a CAD$20 million financing at a unit price of CAD$2.25.
Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
Entheon acquires a genetic screening company to identify genetic markers that affect reactions to hallucinogenic drugs.
Mydecine Innovations Group Upsizes Previously Announced Bought Deal
Mydecine's bought-deal financing is upsized by 50% to CAD $15 million.
MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience
MindMed's new Chief Development Officer has over a decade of experience leading drug development programs.
Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units
Mydecine announces a bought-deal financing with units priced at CAD$0.50.
Novamind Expands Psychedelic Medicine Access in Utah
Novamind Inc announces the expansion and optimization of its Cedar Psychiatry clinic in Utah.
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
Core One Labs announces a research breakthrough to help improve consistency in psilocybin dosing.
Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition
Cybin announces the API synthesis of multiple tryptamine derivatives.